Jay S. Duker - Jan 3, 2025 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Jan 3, 2025
Transactions value $
-$135,675
Form type
4
Date filed
1/7/2025, 04:03 PM
Previous filing
Jul 12, 2024
Next filing
Feb 11, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +30K +78.89% $0.00 68K Jan 5, 2025 Direct
transaction EYPT Common Stock Tax liability -$82.7K -10K -14.71% $8.26 58K Jan 5, 2025 Direct F1
transaction EYPT Common Stock Options Exercise $0 +20.8K +35.84% $0.00 78.8K Jan 6, 2025 Direct
transaction EYPT Common Stock Tax liability -$53K -6.11K -7.75% $8.68 72.7K Jan 6, 2025 Direct F1
holding EYPT Common Stock 22.5K Jan 3, 2025 By Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Award $0 +195K +584.99% $0.00 228K Jan 3, 2025 Common Stock 195K $0.00 Direct F3
transaction EYPT Stock Option (Right to Buy) Award $0 +390K $0.00 390K Jan 3, 2025 Common Stock 390K $8.26 Direct F4
transaction EYPT Restricted Stock Units Options Exercise $0 -30K -33.33% $0.00 60K Jan 5, 2025 Common Stock 30K $0.00 Direct F5
transaction EYPT Restricted Stock Units Options Exercise $0 -20.8K -34.66% $0.00 39.2K Jan 6, 2025 Common Stock 20.8K $0.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units.
F2 These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3 The restricted stock units will vest in three ratable annual installments beginning January 3, 2026.
F4 The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.
F5 The restricted stock units vests in three ratable annual installments beginning January 5, 2025.
F6 The restricted stock units vests in three ratable annual installments beginning January 6, 2024.